Predictors of hypogammaglobulinemia and serious infections among patients receiving ocrelizumab or rituximab for treatment of MS and NMOSD
Veronica Mears, Collin Jakubecz, Catherine N. Seeco, Sophia Woodson, Alessandro Serra, Hesham Abboud
Topics & Concepts
HypogammaglobulinemiaOcrelizumabMedicineRituximabDermatologyImmunologyPediatricsAntibodyImmunodeficiency and Autoimmune DisordersMultiple Sclerosis Research StudiesPlatelet Disorders and Treatments